Search for dissertations about: "Diabetes, hypertension, PhD thesis"

Showing result 1 - 5 of 11 swedish dissertations containing the words Diabetes, hypertension, PhD thesis.

  1. 1. Predictors of Dementia : Insulin, Fatty Acids and Vascular Risk Factors

    Author : Elina Rönnemaa; Lena Kilander; Lars Lannfelt; Björn Zethelius; Laura Fratiglioni; Uppsala universitet; []
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; dementia; Alzheimer’s disease; vascular dementia; insulin secretion; diabetes; fatty acids; epidemiology; vascular risk factors; Geriatrics; Geriatrik;

    Abstract : Identification of modifiable risk factors for Alzheimer’s disease (AD) is crucial in order to diminish suffering from this devastating disease. The aim of this thesis was to investigate if different aspects of glucose metabolism, insulin, fatty-acid composition or other vascular risk factors predict the future development of AD and dementia. READ MORE

  2. 2. The epidemiology of risk factors and short and long-term outcome in the Swedish intensive care cohort

    Author : Björn Ahlström; Miklos Lipcsey; Ing-Marie Larsson; Gunnar Strandberg; Karl Michaëlsson; Uppsala universitet; []
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Epidemiology; Sepsis; Risk factors; Dementia; Coronavirus; Medicinsk vetenskap; Medical Science;

    Abstract : Dissertation presented at Uppsala University to be publicly examined on Zoom: https://uu-se.zoom.us/j/7214327760, Tuesday, 11 May 2021 at 13:00 for the degree of Licentiate of Philosophy (Faculty of Medicine). The examination will be conducted in English and Swedish. READ MORE

  3. 3. Metabolic and endocrine effects of SGLT2 inhibition

    Author : Per Lundkvist; Jan Eriksson; Lars Lind; Maria J Pereira; Michael Alvarsson; Uppsala universitet; []
    Keywords : SGLT2 inhibition; GLP-1 receptor agonism; DPP4 inhibition; NAFLD; prediabetes; type 2 diabetes; obesity; metabolic syndrome; glucagon.; Medicinsk vetenskap; Medical Science;

    Abstract : Obesity and type 2 diabetes (T2D) are two growing global health problems with similar comorbidity profiles. SGLT2 inhibitors (SGLT2i) improve blood glucose control and can relieve both T2D and obesity, as well as their associated health problems such as hypertension, kidney failure, and cardiovascular disease. READ MORE

  4. 4. Socioeconomic and sex differences in adolescents’ dietary intake, anthropometry and physical activity in Cameroon, Africa

    Author : Léonie Dapi N.; Urban Janlert; Christel Larsson; Agneta Hörnell; Thorkild Tylleskär; Umeå universitet; []
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Adolescents; socioeconomic; energy intake; nutrient intake; physical activity; under-overweight; Cameroon; Public health science; Folkhälsovetenskap; näringslära; Nutrition;

    Abstract : Background: People in Cameroon are experiencing a dietary transition characterized by changing from traditional food habits to increased intake of highly processed sweet and fatty food. The rapid change in food pattern combined with an increased sedentary lifestyle has resulted in a rather high prevalence of obesity, hypertension, cardiovascular diseases and type 2 diabetes. READ MORE

  5. 5. Pathophysiological role and clinical relevance of cytokines in hypertensive heart failure. A combined clinical and experimental study

    Author : Espen Haugen; Göteborgs universitet; []
    Keywords : Heart failure; cytokines; elderly; hypertension; cardiac remodelling; interleukin 6; etanercept; adiponectin;

    Abstract : Although mortality due to heart failure has decreased significantly in the last decade since the introduction of ACE-inhibitors and ?-adrenergic receptor blockers in the management of heart failure, chronic heart failure is still one of the most important causes of morbidity and mortality and has a very high frequency for readmission to hospitalization because of the aggravation of heart failure. This accounts for a significantly higher health-care expenditure that is twice as much the cost for cancer. READ MORE